Find a Tender
complete
Official procurement procedure
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published13
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine". Published status: complete. Published value: Value not published. 13 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
9.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 974 active published awards; 798 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published8 Sept 2023, 08:42 BST | Last source update8 Sept 2023, 08:42 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-03b0c5 | ||
What is being bought
Supply of Gastro Intestinal, Endocrine, Nutrition & Blood Medicines to NHS Scotland.
What changed
From the official release history
- tender value changed
8 Sept 2023, 08:42 BST - Status changed to complete
8 Sept 2023, 08:42 BST - Official notice release published
8 Sept 2023, 08:42 BST - Submission deadline changed to published date
8 Sept 2023, 08:42 BST - Published value updated to £45,417,523
9 Mar 2023, 09:07 GMT - Status changed to active
9 Mar 2023, 09:07 GMT - Official notice release published
9 Mar 2023, 09:07 GMT - Submission deadline changed to 11 Apr 2023, 12:00 BST
9 Mar 2023, 09:07 GMT - Buyer information updated
9 Mar 2023, 09:07 GMT
Lots and requirements (13)
Published by the contracting authority
- Lot 1 · #1Desferrioxamine InjectionscancelledPublished valueNot publishedSupply of Desferrioxamine Injections to NHS Scotland. The Authority has awarded this framework as a single supplier framework per lot to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #10All Other PresentationscancelledPublished valueNot publishedSupply of all other presentations to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #11TrientinecancelledPublished valueNot publishedSupply of Trientine to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #12Teriparatide InjectionscancelledPublished valueNot publishedSupply of Teriparatide Injections to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #13Tolvaptan TabletscancelledPublished valueNot publishedSupply of Tolvaptan Tablets to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #14Sapropterin & Deferasriox TabletscancelledPublished valueNot publishedSupply of Sapropterin & Deferasriox Tablets to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #2Dexamethasone InjectioncancelledPublished valueNot publishedSupply of Dexamethasone Injections to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #3Macrogol Oral Powder & SolutionscancelledPublished valueNot publishedSupply of Macrogol Oral Powder & Solutions to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of three (3) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #4MesalazinecancelledPublished valueNot publishedSupply of Mesalazine to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #5Magnesium sulfatecancelledPublished valueNot publishedSupply of Magnesium sulfate to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #6Colecalciferol & Calcium Carbonate tabletscancelledPublished valueNot publishedSupply of Colecalciferol & Calcium Carbonate tablets to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of eight (8) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #7BudesonidecancelledPublished valueNot publishedSupply of Budesonide to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of three (3) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #9PancreatincancelledPublished valueNot publishedSupply of Pancreatin to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of two (2) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
8 Sept 2023, 08:42 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 21 Jun 2023, 00:00 BST · £357,817 - Contract active
Signed 21 Jun 2023, 00:00 BST · £1,415,369 - Contract active
Signed 21 Jun 2023, 00:00 BST · £2,090,164 - Contract active
Signed 21 Jun 2023, 00:00 BST · £145,484 - Contract active
Signed 21 Jun 2023, 00:00 BST · £494,600 - Contract active
Signed 21 Jun 2023, 00:00 BST · £4,570,919 - Contract active
Signed 21 Jun 2023, 00:00 BST · £384,016 - Contract active
Signed 21 Jun 2023, 00:00 BST · £270,449 - Contract active
Signed 21 Jun 2023, 00:00 BST · £232,335 - Contract active
Signed 21 Jun 2023, 00:00 BST · £220,973 - Contract active
Signed 21 Jun 2023, 00:00 BST · £697,314 - Contract active
Signed 21 Jun 2023, 00:00 BST · £23,844,830 - Contract active
Signed 21 Jun 2023, 00:00 BST · £1,419,890
Commercial outcome and competition
Awards Kent Pharmaceuticals Ltd Not published · Not published · active Accord, Eli Lilly & Company Limited, Gedeon Richter, Teva UK Limited, Thornton & Ross Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active MSN Labs, Teva UK Limited, Viatris UK Healthcare Ltd Not published · Not published · active CST Pharma Ltd, Kent Pharmaceuticals Ltd, P M Pharma Ltd, Panpharma UK Ltd, Pfizer Limited, Wockhardt UK Limited, hameln pharma ltd Not published · Not published · active Galen Ltd, Norgine Pharmaceuticals Limited, Stirling Anglian Pharmaceuticals Not published · Not published · active Accord, Consilient Health Ltd, Day Lewis Medical Ltd, Galen Ltd, Kyowa Kirin, Stirling Anglian Pharmaceuticals, Teva UK Limited, Thornton & Ross Ltd Not published · Not published · active CST Pharma Ltd, Kent Pharmaceuticals Ltd, Martindale Pharma, P M Pharma Ltd, Synchrony Pharma Ltd Not published · Not published · active AbbVie Ltd, Day Lewis Medical Ltd, Dr Falk Pharma UK Ltd, Ferring Pharmaceuticals Limited, Galen Ltd, Takeda UK Limited, Tillotts Pharma UK Ltd Not published · Not published · active Day Lewis Medical Ltd, Dr Falk Pharma UK Ltd, Tillotts Pharma UK Ltd Not published · Not published · active Day Lewis Medical Ltd, Viatris UK Healthcare Ltd Not published · Not published · active Accord, Aspire Pharma Ltd, Bristol Laboratories Ltd, Brown and Burk, Chiesi Limited, Colonis Pharma Ltd, Consilient Health Ltd, Crescent Pharma Limited, Day Lewis Medical Ltd, Dr Falk Pharma UK Ltd, Dr. Reddy's Laboratories, Ennogen Healthcare Ltd, Eurocept International, Ferring Pharmaceuticals Limited, Focus Pharmaceuticals Ltd, Galen Ltd, GlaxoSmithKline, Glenmark Pharmaceuticals Europe Ltd, Intrapharm Laboratories Ltd, Kent Pharmaceuticals Ltd, Kyowa Kirin, Martindale Pharma, Medreich PLC, Mercury Pharma Group, Morningside Pharmaceuticals Limited, Norgine Pharmaceuticals Limited, Panpharma UK Ltd, Pfizer Limited, RPH Pharma Ltd, Ranbaxy (UK) Ltd, Reckitt Benckiser, Rosemont Pharmaceuticals, Sandoz Ltd, Selective Supplies Ltd, Synchrony Pharma Ltd, Teva UK Limited, Thornton & Ross Ltd, Typharm Ltd, Viatris UK Healthcare Ltd, Wockhardt UK Limited, Zentiva Pharma UK Ltd, hameln pharma ltd Not published · Not published · active Orphalan Ltd, Univar Solutions B.V Not published · Not published · active |
Contracts Desferrioxamine Injections £357,817 · signed 21 Jun 2023, 00:00 BST · active Teriparatide Injections £1,415,369 · signed 21 Jun 2023, 00:00 BST · active Tolvaptan Tablets £2,090,164 · signed 21 Jun 2023, 00:00 BST · active Sapropterin & Deferasriox Tablets £145,484 · signed 21 Jun 2023, 00:00 BST · active Dexamethasone Injection £494,600 · signed 21 Jun 2023, 00:00 BST · active Macrogol Oral Powder & Solutions £4,570,919 · signed 21 Jun 2023, 00:00 BST · active Colecalciferol & Calcium Carbonate tablets £384,016 · signed 21 Jun 2023, 00:00 BST · active Magnesium sulfate £270,449 · signed 21 Jun 2023, 00:00 BST · active Mesalazine £232,335 · signed 21 Jun 2023, 00:00 BST · active Budesonide £220,973 · signed 21 Jun 2023, 00:00 BST · active Pancreatin £697,314 · signed 21 Jun 2023, 00:00 BST · active All Other Presentations £23,844,830 · signed 21 Jun 2023, 00:00 BST · active Trientine £1,419,890 · signed 21 Jun 2023, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 0 (lot 1) bids: 46 (lot 10) electronicBids: 46 (lot 10) foreignBidsFromEU: 1 (lot 10) foreignBidsFromNonEU: 45 (lot 10) smeBids: 35 (lot 10) bids: 2 (lot 11) electronicBids: 2 (lot 11) foreignBidsFromEU: 2 (lot 11) foreignBidsFromNonEU: 0 (lot 11) smeBids: 2 (lot 11) bids: 5 (lot 12) electronicBids: 5 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 5 (lot 12) smeBids: 3 (lot 12) bids: 1 (lot 13) electronicBids: 1 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 1 (lot 13) smeBids: 1 (lot 13) bids: 7 (lot 14) electronicBids: 7 (lot 14) foreignBidsFromEU: 0 (lot 14) foreignBidsFromNonEU: 7 (lot 14) smeBids: 2 (lot 14) bids: 7 (lot 2) electronicBids: 7 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 7 (lot 2) smeBids: 5 (lot 2) bids: 3 (lot 3) electronicBids: 3 (lot 3) foreignBidsFromEU: 0 (lot 3) foreignBidsFromNonEU: 3 (lot 3) smeBids: 2 (lot 3) bids: 7 (lot 4) electronicBids: 7 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromNonEU: 7 (lot 4) smeBids: 2 (lot 4) bids: 5 (lot 5) electronicBids: 5 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromNonEU: 5 (lot 5) smeBids: 4 (lot 5) bids: 8 (lot 6) electronicBids: 8 (lot 6) foreignBidsFromEU: 0 (lot 6) foreignBidsFromNonEU: 8 (lot 6) smeBids: 6 (lot 6) bids: 3 (lot 7) electronicBids: 3 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromNonEU: 3 (lot 7) smeBids: 2 (lot 7) bids: 2 (lot 9) electronicBids: 2 (lot 9) foreignBidsFromEU: 0 (lot 9) foreignBidsFromNonEU: 2 (lot 9) smeBids: 2 (lot 9) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contracting authority GB-FTS-322Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published